Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on May 19, 2014 11:26am
428 Views
Post# 22575334

RE:RE:Pirfenidone

RE:RE:PirfenidoneAliBaba, and why this should be bad news for PLI? We are talking about 2 drugs with a different mechanism of action. It's not because perfenidone have positive results that it means there will be no market for PBI-4050. Remember, when you have an headake, You can take aspirin, acetamenophen or ibuprofen. They all work in a different way. Another expample is the treatment for AIDS, they used a tri-therapy, just not one single pill.....
Bullboard Posts